封面
市場調查報告書
商品編碼
1467551

2024-2032 年按成分(血漿、血小板、白血球、淋巴細胞、紅血球)、產品、技術、程序、應用、最終用戶和地區分類的單採市場報告

Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2023年,IMARC Group單採市場規模達29億美元。

單採術是分離捐贈的血液成分(例如紅血球(RBC)、白血球(WBC)、血小板和血漿)以治療各種疾病的過程。它有助於治療鐮狀細胞疾病,其中紅血球(RBC)形狀異常並且無法將氧氣輸送到體內。它也用於去除使血液變稠並干擾器官功能的異常白血球 (WBC)。此外,由於單採術有助於治療血癌和血液疾病,例如重症肌無力和血栓性血小板減少性紫斑症 (TTP),因此在全球的採血中心、醫院和門診中心廣泛使用。

單採市場趨勢:

對治療自體免疫性溶血性貧血、急性播散性腦脊髓炎和心臟新生兒狼瘡等各種疾病的單採術的需求不斷成長,是推動市場的關鍵因素之一。除此之外,全球使用單採術收集血漿來治療燒傷和創傷患者的情況增加。這與蓬勃發展的醫療保健行業一起促進了市場的成長。此外,主要市場參與者增加對研發(R&D)活動的​​投資,以推出治療嚴重閉塞性動脈硬化的增強型血液淨化設備,這對市場產生了積極影響。此外,治療原發性免疫缺陷和血友病的血漿源需求不斷成長,為行業投資者提供了利潤豐厚的成長機會。除此之外,單採術擴大用於治療各種疾病,如血栓性血小板減少性紫斑症、溶血性尿毒症症候群、藥物毒性、自體免疫疾病、敗血症和暴發性肝衰竭,這提供了積極的市場前景。此外,大眾對單採術好處的認知不斷增強,也促進了市場的成長。

本報告回答的關鍵問題

  • 2023年全球單採市場規模有多大?
  • 2024-2032年全球單採市場的預期成長率是多少?
  • 推動全球單採市場的關鍵因素是什麼?
  • COVID-19 對全球單採市場有何影響?
  • 全球單採市場依成分分類是怎樣的?
  • 基於該產品的全球單採市場的詳細情形如何?
  • 基於該技術的全球單採市場的詳細情形如何?
  • 全球單採市場依程序分類是怎樣的?
  • 根據應用,全球單採市場的細分如何?
  • 基於最終用戶的全球單採市場的細分如何?
  • 全球單採市場的關鍵區域有哪些?
  • 全球單採市場的主要參與者/公司有哪些?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球單採市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:按組成部分

  • 血漿(血漿去除術)
    • 市場走向
    • 市場預測
  • 血小板(血小板去除術)
    • 市場走向
    • 市場預測
  • 白血球(白血球去除術或白血球去除術)
    • 市場走向
    • 市場預測
  • 淋巴球(淋巴球分離術或淋巴分離術)
    • 市場走向
    • 市場預測
  • 紅血球(紅血球去除術)
    • 市場走向
    • 市場預測

第 7 章:市場區隔:依產品

  • 裝置
    • 市場走向
    • 市場預測
  • 一次性用品和試劑
    • 市場走向
    • 市場預測
  • 軟體
    • 市場走向
    • 市場預測

第 8 章:市場區隔:依技術

  • 離心
    • 市場走向
    • 市場預測
  • 膜分離
    • 市場走向
    • 市場預測
  • 選擇性吸附
    • 市場走向
    • 市場預測

第 9 章:市場區隔:依程序

  • 供體/自動血漿分離術
    • 市場走向
    • 市場預測
  • 治療性血漿分離術
    • 市場走向
    • 市場預測

第 10 章:市場區隔:按應用

  • 腎臟疾病
    • 市場走向
    • 市場預測
  • 血液系統疾病
    • 市場走向
    • 市場預測
  • 神經系統疾病
    • 市場走向
    • 市場預測
  • 自體免疫疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章:市場區隔:依最終用戶

  • 血液中心
    • 市場走向
    • 市場預測
  • 醫院
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 12 章:市場區隔:按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分:按國家/地區
    • 市場預測

第 13 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 14 章:價值鏈分析

第 15 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 16 章:價格分析

第17章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
    • B. Braun SE
    • Charles River Laboratories International Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Haemonetics Corporation
    • Haier Biomedical
    • Kaneka Corporation
    • Medica Spa
    • Miltenyi Biotec
    • Nikkiso Co. Ltd.
    • Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
    • Terumo Bct Inc. (Terumo Corporation)
Product Code: SR112024A6477

The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032.

Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

Apheresis Market Trends:

The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, product, technology, procedure, application and end user.

Breakup by Component:

Plasma (Plasmapheresis)

Platelets (Plateletpheresis)

Leukocytes (Leukapheresis or Leukopheresis)

Lymphocytes (Lymphopheresis or Lymphapheresis)

RBC's (Erythropheresis)

Breakup by Product:

Devices

Disposables and Reagents

Software

Breakup by Technology:

Centrifugation

Membrane Separation

Selective Adsorption

Breakup by Procedure:

Donor/Automated Apheresis

Therapeutic Apheresis

Breakup by Application:

Renal Disorders

Hematological Disorders

Neurological Disorders

Autoimmune Disorders

Others

Breakup by End User:

Blood Centers

Hospitals

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), B. Braun SE, Charles River Laboratories International Inc., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Kaneka Corporation, Medica S.p.a., Miltenyi Biotec, Nikkiso Co. Ltd., Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).

Key Questions Answered in This Report

  • 1. What was the size of the global apheresis market in 2023?
  • 2. What is the expected growth rate of the global apheresis market during 2024-2032?
  • 3. What are the key factors driving the global apheresis market?
  • 4. What has been the impact of COVID-19 on the global apheresis market?
  • 5. What is the breakup of the global apheresis market based on the component?
  • 6. What is the breakup of the global apheresis market based on the product?
  • 7. What is the breakup of the global apheresis market based on the technology?
  • 8. What is the breakup of the global apheresis market based on procedure?
  • 9. What is the breakup of the global apheresis market based on the application?
  • 10. What is the breakup of the global apheresis market based on the end user?
  • 11. What are the key regions in the global apheresis market?
  • 12. Who are the key players/companies in the global apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Apheresis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Plasma (Plasmapheresis)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platelets (Plateletpheresis)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Leukocytes (Leukapheresis or Leukopheresis)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 RBC's (Erythropheresis)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disposables and Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Centrifugation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Membrane Separation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Selective Adsorption
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Procedure

  • 9.1 Donor/Automated Apheresis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Apheresis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Renal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hematological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Neurological Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Autoimmune Disorders
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Blood Centers
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Hospitals
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 B. Braun SE
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Charles River Laboratories International Inc.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Fresenius Medical Care AG & Co. KGaA
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Haemonetics Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Haier Biomedical
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Kaneka Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medica S.p.a.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Miltenyi Biotec
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
    • 17.3.10 Nikkiso Co. Ltd.
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
      • 17.3.10.3 Financials
      • 17.3.10.4 SWOT Analysis
    • 17.3.11 Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Bct Inc. (Terumo Corporation)
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Apheresis Market: Major Drivers and Challenges
  • Figure 2: Global: Apheresis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Apheresis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Apheresis Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Apheresis Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Apheresis Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Apheresis Market: Breakup by Procedure (in %), 2023
  • Figure 8: Global: Apheresis Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Apheresis Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Apheresis Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Apheresis (Plasma (Plasmapheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Apheresis (Plasma (Plasmapheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Apheresis (Platelets (Plateletpheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Apheresis (Platelets (Plateletpheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Apheresis (RBC's (Erythropheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Apheresis (RBC's (Erythropheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Apheresis (Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Apheresis (Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Apheresis (Disposables and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Apheresis (Disposables and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Apheresis (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Apheresis (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Apheresis (Centrifugation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Apheresis (Centrifugation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Apheresis (Membrane Separation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Apheresis (Membrane Separation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Apheresis (Selective Adsorption) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Apheresis (Selective Adsorption) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Apheresis (Donor/Automated Apheresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Apheresis (Donor/Automated Apheresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Apheresis (Therapeutic Apheresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Apheresis (Therapeutic Apheresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Apheresis (Renal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Apheresis (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Apheresis (Hematological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Apheresis (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Apheresis (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Apheresis (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Apheresis (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Apheresis (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Apheresis (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Apheresis (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Apheresis (Blood Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Apheresis (Blood Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Apheresis (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Apheresis (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Apheresis (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Apheresis (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Asia-Pacific: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Asia-Pacific: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: China: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: China: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Japan: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Japan: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: India: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: India: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: South Korea: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: South Korea: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Australia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Australia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Indonesia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Indonesia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Europe: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Europe: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Germany: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Germany: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: France: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: France: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: United Kingdom: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: United Kingdom: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Italy: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Italy: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Spain: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Spain: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Russia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Russia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Apheresis Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Apheresis Industry: SWOT Analysis
  • Figure 103: Global: Apheresis Industry: Value Chain Analysis
  • Figure 104: Global: Apheresis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Apheresis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Apheresis Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Apheresis Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Apheresis Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Apheresis Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 6: Global: Apheresis Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Apheresis Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Apheresis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Apheresis Market: Competitive Structure
  • Table 10: Global: Apheresis Market: Key Players